Top Court Rebukes EU for Overreach in Smaller Takeover Review
- European Union competition regulators’ powers curbed by top court
- EU lacked jurisdiction over Illumina’s acquisition of cancer-test maker Grail
- Decision expected to trigger wider debate on handling deals with potential competition threats
- Business groups welcome the ruling as a ‘cold shower’ for regulators
- EU may consider changes in recent years to review more cases within court’s ruling
The European Court of Justice ruled that the EU competition authority lacked jurisdiction over U.S. gene-sequencing company Illumina’s acquisition of cancer-test maker Grail, limiting its powers to target smaller takeovers. The decision is expected to trigger a wider debate on how to handle deals with potential competition threats where the acquired company has little or no revenue in the EU. Business groups welcome the ruling as it may discourage overreach by regulators. The European Commission will study implications and consider changes to review cases not meeting traditional thresholds while complying with the court’s ruling.
Image Credits: no
Factuality Level: 8
Factuality Justification: The article provides accurate and objective information about the European Court of Justice’s ruling on EU competition regulators’ overreach in a specific case involving Illumina and Grail. It also discusses the potential implications for future deal scrutiny and the possible changes in approach by the European Commission. The article includes quotes from experts in the field, providing diverse perspectives on the issue.
Noise Level: 6
Noise Justification: The article provides relevant information about the European Court of Justice’s ruling on the EU competition authority’s jurisdiction and its implications for future deal scrutiny but lacks in-depth analysis or actionable insights. It also includes some repetitive information and relies on quotes from legal professionals without offering a comprehensive perspective.
Public Companies: Illumina (ILMN)
Private Companies: Grail
Key People: Margrethe Vestager (EU competition chief), Kasia Czapracka (partner with law firm White & Case), Alec Burnside (senior counsel with law firm Dechert LLP)
Financial Relevance: Yes
Financial Markets Impacted: The decision by the European Court of Justice could impact the EU’s approach to policing deals that fall below traditional thresholds for review, potentially affecting mergers and acquisitions in the region.
Financial Rating Justification: This article discusses a court ruling that impacts the European Union’s competition authority and its ability to review smaller takeovers, which can affect mergers and acquisitions within the EU. This has implications on companies operating in the region and could potentially impact financial markets as well.
Presence Of Extreme Event: No
Nature Of Extreme Event: Other
Impact Rating Of The Extreme Event: Minor
Extreme Rating Justification: There is no extreme event mentioned in the article. The decision by the European Court of Justice regarding Illumina’s takeover of Grail may have implications for EU competition regulation, but it does not qualify as an extreme event.
Deal Size: The deal size mentioned in this article is $477 million.
Move Size: No market move size mentioned.
Sector: Technology
Direction: Up
Magnitude: Small
Affected Instruments: Stocks
www.wsj.com 
